324 related articles for article (PubMed ID: 31728750)
1. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
3. Objective Outcomes of an Extended Anti-reflux Mucosectomy in the Treatment of PPI-Dependent Gastroesophageal Reflux Disease (with Video).
He J; Yin Y; Tang W; Jiang J; Gu L; Yi J; Yan L; Chen S; Wu Y; Liu X
J Gastrointest Surg; 2022 Aug; 26(8):1566-1574. PubMed ID: 35776296
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux disease.
Warren HF; Brown LM; Mihura M; Farivar AS; Aye RW; Louie BE
Surg Endosc; 2018 Jan; 32(1):405-412. PubMed ID: 28664433
[TBL] [Abstract][Full Text] [Related]
5. The long-term efficacy of transoral incisionless fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease.
Shen S; Yu G; Guo X; Zong G; Wang C; Bao J; Chen J; Cheng Z; Xiao W; Shen J; Jiang W; Wan R
Esophagus; 2023 Jul; 20(3):581-586. PubMed ID: 36877412
[TBL] [Abstract][Full Text] [Related]
6. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
[TBL] [Abstract][Full Text] [Related]
8. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease.
Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oxenberg D; Perez-Castilla A; Netto MG; Soffer E; Boscardin WJ; Crowell MD
Surgery; 2015 Mar; 157(3):556-67. PubMed ID: 25726315
[TBL] [Abstract][Full Text] [Related]
9. [The role of the traditional surgical procedures for gastroesophageal reflux disease cannot be ignored].
Zhou JH; Tan QY
Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):672-676. PubMed ID: 32878412
[TBL] [Abstract][Full Text] [Related]
10. Short and long term effect of anti-reflux mucosectomy with cap-assisted endoscopic mucosal resection for refractory gastroesophageal disease.
Lee YS; Kim JH; Yon DK; Yoo IK
Surg Endosc; 2024 Apr; 38(4):2180-2187. PubMed ID: 38448622
[TBL] [Abstract][Full Text] [Related]
11. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
Watson TJ; Peters JH
Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of endoscopic cardia peripheral tissue scar formation (ECSF) for the treatment of refractory gastroesophageal reflux disease: A systematic review with meta-analysis.
Shi C; ZhuoMa G; Ying L; Zhang Z; Cui L; Li R; Zhang J
Medicine (Baltimore); 2024 Mar; 103(10):e37062. PubMed ID: 38457552
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial.
Kalapala R; Karyampudi A; Nabi Z; Darisetty S; Jagtap N; Ramchandani M; Gupta R; Lakhtakia S; Goud R; Venkat Rao G; Sharma P; Reddy DN
Gut; 2022 Apr; 71(4):686-694. PubMed ID: 33849942
[TBL] [Abstract][Full Text] [Related]
16. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
[TBL] [Abstract][Full Text] [Related]
17. Electrical stimulation of the lower esophageal sphincter to address gastroesophageal reflux disease after sleeve gastrectomy.
Borbély Y; Bouvy N; Schulz HG; Rodriguez LA; Ortiz C; Nieponice A
Surg Obes Relat Dis; 2018 May; 14(5):611-615. PubMed ID: 29567054
[TBL] [Abstract][Full Text] [Related]
18. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
19. Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication.
Bell RC; Fox MA; Barnes WE; Mavrelis PG; Sewell RW; Carter BJ; Ihde GM; Trad KS; Dargis D; Hoddinott KM; Freeman KD; Gunsberger T; Hausmann MG; Gill BD; Wilson E
Surg Endosc; 2014 Oct; 28(10):2949-58. PubMed ID: 24879134
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.
Ota K; Takeuchi T; Kojima Y; Sugawara N; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Tokioka S; Higuchi K
BMC Gastroenterol; 2021 Nov; 21(1):432. PubMed ID: 34794376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
